↓ Skip to main content

Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation

Overview of attention for article published in Frontiers in immunology, January 2021
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation
Published in
Frontiers in immunology, January 2021
DOI 10.3389/fimmu.2020.616570
Pubmed ID
Authors

Linda Voss, Karina Guttek, Annika Reddig, Annegret Reinhold, Martin Voss, Burkhart Schraven, Dirk Reinhold

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 25%
Student > Doctoral Student 2 25%
Student > Bachelor 1 13%
Student > Master 1 13%
Unknown 2 25%
Readers by discipline Count As %
Immunology and Microbiology 3 38%
Biochemistry, Genetics and Molecular Biology 2 25%
Agricultural and Biological Sciences 1 13%
Medicine and Dentistry 1 13%
Unknown 1 13%